about
The role of purinergic receptors in cancer-induced bone painThe search for novel analgesics: targets and mechanismsGlial cells and chronic painMechanisms of acupuncture-electroacupuncture on persistent painMAPK pathway activation in pilocytic astrocytomaAMPK: An emerging target for modification of injury-induced pain plasticity.Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell deathEmerging targets in neuroinflammation-driven chronic painEmerging roles of resolvins in the resolution of inflammation and painAnti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppressionHemokinin-1 gene expression is upregulated in microglia activated by lipopolysaccharide through NF-κB and p38 MAPK signaling pathwaysIL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in ratsInhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic painAdenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain.Preventive analgesia by local anesthetics: the reduction of postoperative pain by peripheral nerve blocks and intravenous drugs.Nicotine dependence produces hyperalgesia: role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA).Genetic targeting of ERK1 suggests a predominant role for ERK2 in murine pain modelsQuantitative automated microscopy (QuAM) elucidates growth factor specific signalling in pain sensitizationTemporomandibular joint pain: a critical role for Trpv4 in the trigeminal ganglion.The Qualitative Hyperalgesia Profile: A New Metric to Assess Chronic Post-Thoracotomy Pain.TANK-binding kinase 1 (TBK1) modulates inflammatory hyperalgesia by regulating MAP kinases and NF-κB dependent genes.The mitogen and stress-activated protein kinase 1 regulates the rapid epigenetic tagging of dorsal horn neurons and nocifensive behaviourEffects of estrogens and bladder inflammation on mitogen-activated protein kinases in lumbosacral dorsal root ganglia from adult female ratsGenome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.Qingkailing Suppresses the Activation of BV2 Microglial Cells by Inhibiting Hypoxia/Reoxygenation-Induced Inflammatory Responses.The c-Jun N-terminal kinase 1 (JNK1) in spinal astrocytes is required for the maintenance of bilateral mechanical allodynia under a persistent inflammatory pain conditionChronic tooth pulp inflammation induces persistent expression of phosphorylated ERK (pERK) and phosphorylated p38 (pp38) in trigeminal subnucleus caudalis.The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target (Review).N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory pain.Rutin attenuates isoflurane-induced neuroapoptosis via modulating JNK and p38 MAPK pathways in the hippocampi of neonatal rats.Tumor necrosis factor α modulates sodium-activated potassium channel SLICK in rat dorsal horn neurons via p38 MAPK activation pathwayCooperation of TLR2 with MyD88, PI3K, and Rac1 in lipoteichoic acid-induced cPLA2/COX-2-dependent airway inflammatory responses.Resveratrol-decreased hyperalgesia mediated by the P2X7 receptor in gp120-treated ratsActivation of Extracellular Signal-Regulated Kinases (ERK 1/2) in the Locus Coeruleus Contributes to Pain-Related Anxiety in Arthritic Male RatsGp120 in the pathogenesis of human immunodeficiency virus-associated pain.Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord.[EXPRESS] CXCL12/CXCR4 signaling mediated ERK1/2 activation in spinal cord contributes to the pathogenesis of postsurgical pain in rats.p38 mediates mechanical allodynia in a mouse model of type 2 diabetes.The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.Inflammatory cytokines are suppressed by light-emitting diode irradiation of P. gingivalis LPS-treated human gingival fibroblasts: inflammatory cytokine changes by LED irradiation.
P2860
Q21284976-A9322040-909D-46B3-8789-E28113F35B0CQ24288817-F8A44304-3409-4BF8-8A9B-152A5AA76789Q24603427-9430830A-001F-47CD-8897-8E28AE3C28FFQ26866252-819E9BBD-5D82-49EF-A66D-CD767398C240Q27006028-FD37194B-57B8-4EAD-852E-C5E68B25B497Q27021903-F7D5C464-786E-446A-AF4E-7C6AB735E74BQ28080874-01BA12FD-2098-4958-B573-E2B08FDA127CQ28242435-2C43704B-4CB2-4C64-8655-6400FA35A048Q28249435-421B1F46-8309-4F07-A784-A7BDF772A84FQ28468568-0A5712BD-60B2-46FC-9406-E470B65EF5BAQ28481288-A013BE80-330F-407A-BD66-6DB8403CBAC6Q28577054-EEA94E3D-3208-4827-8E6F-8B4328EEB520Q28649336-126E21C0-6786-4068-9C45-67CFAB7DD29EQ30383901-E50E70A7-120D-4C65-8428-28E742403637Q30413263-318E8C07-9997-4395-A4F4-B7582EA76980Q30419954-E2F13078-4303-4A9F-B4FE-4B605C023B00Q30496403-18365F8C-AA03-4DC8-AE55-E017F8003E1CQ30497951-3C3DE783-7934-4835-B5BF-B45D5ED681B0Q30541798-D5DED432-F434-4AE6-8288-BA8860CA3DFBQ30572453-0A7B45DF-FED7-4210-BE00-F00B18443A39Q30652436-F506CAB9-4CF6-4874-B1C5-8A306A755C92Q30822808-0F9937F1-148E-4388-A94F-B663F2F0A90FQ33520834-6C326AF3-3294-4037-A9A6-64A033A879A0Q33589600-DFBCA25B-C2F3-446B-95BD-92D7F8964BB3Q33608619-7C49928E-7492-4C38-A6AB-E428274AE88AQ33624235-09BEB23D-D92B-47BA-B2D7-88FFEF6A3DA7Q33647456-91AB21A9-C6CA-439C-9464-62B83162D7E5Q33674924-F313F0A8-6944-4644-93DE-BE7BE3A827D1Q33701859-633BD019-9907-421F-9EA6-22F8734BB734Q33723931-42D218A7-9356-4D84-B504-15893B8EBE81Q33739821-A2D83CE9-FAAF-418D-9701-675B844CDB00Q33745132-34877B51-F3E7-45D9-B2F5-C4B53292AE76Q33752131-149CC697-16AB-4264-B3A8-D9DD3B3DEBB9Q33762240-DF108ABA-2511-4EF2-9716-9B92A8249DA1Q33831637-23439413-7BC8-416F-B4BD-9C61EB0E9918Q33885584-1619CE81-EF74-4257-915D-F62049751987Q33887632-19880C06-3522-4059-9DA5-8A29D2F6707CQ33895067-F584EFC1-C28D-4E99-AA4E-1FFB6EE88C37Q33947251-8CBA5040-B6FB-4EE1-A588-F40055E119E9Q33981615-45F5092C-BD6E-46A5-9B1A-424512BFF73B
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
MAP kinase and pain.
@ast
MAP kinase and pain.
@en
type
label
MAP kinase and pain.
@ast
MAP kinase and pain.
@en
prefLabel
MAP kinase and pain.
@ast
MAP kinase and pain.
@en
P2860
P1476
MAP kinase and pain.
@en
P2093
Gary R Strichartz
Robert W Gereau
P2860
P304
P356
10.1016/J.BRAINRESREV.2008.12.011
P577
2008-12-25T00:00:00Z